Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA90530
Max Phase: Preclinical
Molecular Formula: C21H20Br2N2O2
Molecular Weight: 492.21
Molecule Type: Small molecule
Associated Items:
ID: ALA90530
Max Phase: Preclinical
Molecular Formula: C21H20Br2N2O2
Molecular Weight: 492.21
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(N/C(C(=O)N1CCCCC1)=C(/Br)c1ccccc1)c1ccc(Br)cc1
Standard InChI: InChI=1S/C21H20Br2N2O2/c22-17-11-9-16(10-12-17)20(26)24-19(18(23)15-7-3-1-4-8-15)21(27)25-13-5-2-6-14-25/h1,3-4,7-12H,2,5-6,13-14H2,(H,24,26)/b19-18+
Standard InChI Key: IQYNOUCSSQAXHF-VHEBQXMUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 492.21 | Molecular Weight (Monoisotopic): 489.9892 | AlogP: 4.96 | #Rotatable Bonds: 4 |
Polar Surface Area: 49.41 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 12.93 | CX Basic pKa: | CX LogP: 4.23 | CX LogD: 4.23 |
Aromatic Rings: 2 | Heavy Atoms: 27 | QED Weighted: 0.61 | Np Likeness Score: -0.93 |
1. Perni RB, Conway SC, Ladner SK, Zaifert K, Otto MJ, King RW.. (2000) Phenylpropenamide derivatives as inhibitors of hepatitis B virus replication., 10 (23): [PMID:11128652] [10.1016/s0960-894x(00)00544-8] |
Source(1):